Arrowhead Pharmaceuticals... (ARWR)

AI Score

Unlock

12.06

0.82 (7.30%)

At close: Apr 21, 2025, 3:59 PM

12.08

0.12%

After-hours: Apr 21, 2025, 06:04 PM EDT

Dividends

No dividend history available for Arrowhead Pharmaceuticals Inc..

Pro Subscription

Upgrade now for unlimited access to all data and tools.

Dividend Definition

Dividends are payments made by a company to its shareholders, typically derived from its profits. They represent a portion of earnings distributed to investors as a reward for holding shares. Dividends do not account for retained earnings or reinvestments and are therefore different from a company's total profits.

Related Stocks

Company	Dividend Yield

Dividend Rankings

ARWR News

1 week ago · Arrowhead Pharmaceuticals Appoints Daniel Apel as Chief Financial Officer - businesswire.com
2 weeks ago · Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - businesswire.com
1 month ago · Arrowhead Pharmaceuticals Is Finally Arriving - seekingalpha.com
1 month ago · Arrowhead Pharmaceuticals Announces Topline Results from Part 2 of Phase 1/2 Study of ARO-C3 in Patients with IgA Nephropathy - businesswire.com
1 month ago · Arrowhead Pharmaceuticals Showcases Two Clinical-Stage RNAi-Based Candidates to Treat Obesity and Metabolic Diseases - businesswire.com
1 month ago · Arrowhead Pharmaceuticals Launches on Rare Disease Day New Patient-Centric Resources for Those Affected by Familial Chylomicronemia Syndrome (FCS) - businesswire.com
1 month ago · Arrowhead Pharmaceuticals Presents Preclinical Data on ARO-ALK7 for Treatment of Obesity - businesswire.com
2 months ago · Arrowhead Pharmaceuticals: Progress During Adverse Market Conditions - seekingalpha.com
2 months ago · Arrowhead Pharmaceuticals, Inc. (ARWR) Q1 2025 Earnings Call Transcript - seekingalpha.com
2 months ago · Arrowhead Pharmaceuticals Reports Fiscal 2025 First Quarter Results - businesswire.com